Rett syndrome (RTT) is a severe neurodevelopmental disorder associated with mutations in the X-linked gene encoding methylCpG-binding protein 2 (MECP2). Despite the fact that this disease has been studied for more than 20 years the problem of genetic and epigenetic factor involvement in the pathogenesis of RTT is not completely solved. In the present review we describe the contemporary knowledge of neurological, genetic and epigenetic features of RTT. We propose that subsequent studies of RTT should be targeted to reveal genotypephenotype correlations taking into account the pathogenic effect of MECP2 mutations as well as X chromosome inactivation. We also suggest that additional investigations of epigenetic phenomena in cells with MECP2 
Introduction
Rett syndrome (RTT) (MIM and OMIM 312750) was originally described as a brain atrophy syndrome by A. Rett in 1966 (1) . Similar clinical features were observed by B. Hagberg's group between 1960 and 1982. These cases were diagnosed under a special eponym, the "Vesslan" disease (from the name of the first girl seen in 1960) (2) . In 1983 B. Hagberg with coworkers reported 35 cases of RTT (3) . Since that time this disease has been investigating in detail and nowadays RTT is considered as one of the most studied X-linked neurological diseases.
In 1999 mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MECP2) were found to be associated with RTT (4) . This discovery allowed the application of molecular genetic techniques for RTT diagnosis and has opened prospects for studying molecular processes leading to complex clinical appearance of RTT girls.
Clinical features
Up to 1983 RTT was considered as idiopathic form of autism or severe childhood-onset schizophrenia (2, 3) . In the present time RTT is classified as an autistic-spectrum disorder or "pervasive developmental disorder" (5) .
RTT affects approximately 1:10,000-1:15,000 females worldwide (6, 7) . The epidemiological studies revealed the non-random geographical distribution of RTT prevalence. The increased frequency of RTT was observed in Albania, England, Hungary, and Norway (6) . It has been estimated that in some regions the occurrence of RTT could spread up to 1:3,000 (8) . The geographical variability of RTT prevalence is shown in Table 1 . This gives an impression that the prevalence of RTT is highly variable. However, it should be noted that most of the population-based studies have shown RTT incidence being in the range from 1:10,000 to 1: 20,000. The studies of RTT in Russia have indicated 2.5% incidence in institutionalized mentally retarded girls (14) .
The manifestation of the disease begins at the age of 6-18 months; however in some cases it could occur directly after birth or at the age of 2-3 years. At birth, affected girls appear to be healthy and develop normally up to the age of manifestation. Then neurological development stops and the onset of total regression of motor, language and social skills begins (3) . RTT has a staging pattern of manifestation comprising four stages. The first stage is quite similar to the classical form of autism. This stage is characterized by minor neurological and behavioral abnormalities, head growth decelerating and autistic features such as emotional withdrawal and diminished eye contact. Although the presence of decelerating head growth would be quite distinct for RTT to exclude classical autism, this feature is not distinct enough to be considered for clinical diagnosis of RTT in the first stage. The second stage shows a dramatic regression characterized by the loss of learned skills such as speech and purposeful hand use. Irregular breathing, truncal and gait ataxia/apraxia and stereotypic hand wringing begin. During the second stage of disease, the skills acquired before the onset are lost. During the third stage some stabilization of the condition is seen. Despite gross cognitive and motor impairment, some improvement of contact and emotional skills is observed. Stage four is characterized by less of the frequent seizure occurrences and the development of scoliosis, which can cause confinement to wheelchairs (15) .
The definition of these four stages is quite rough. The clinical course of RTT is continuous and progressive. The stereotypic hand wringing is considered as the most characteristic clinical feature and is important for clinical diagnosis of the disease. Other stereotypic movements such as biting or suction of the hand, percussion of face and chest are also observed (16) . Head circumference is considered as normal up to the disease onset (17) . After the onset, dramatic head growth deceleration begins. However, in some cases, the head growth deceleration may begin in early infancy well before the disease onset. Intellectual, speech and adaptive skills in females with RTT are strongly limited. Communicative skills are commonly lost at the age of 4-11 months and the loss of purposeful hand use occurs at the age of 12-14 months (16) . Ataxia and apraxia affect principally trunk and limbs and occur as abrupt movements, disequilibrium, tremor and walking disability. Breathing dysfunction as abnormal respiratory rhythm and apnea is relatively common in RTT females. Interestingly the breathing dysfunctions are observed during wakefulness and are absent on sleep (18) . Seizures may affect about 80% of RTT girls; however some authors report a lower seizure rate (even as low as 25%). The seizure occurrence is variable because some paroxysmal events are also present and could be considered as seizures (16) . In about half of girls with RTT the scoliosis develops as a result of muscular dystonia (19) .
The mortality rate is significantly increased (up to 13 times) among RTT females comparing to general population. About 67% of patients attain the age of 30 years. The most common death causes are apnea and seizures, and in many cases the death is sudden (20) . However, a number of patients attain the age of 40 years or more. In our experience the majority of RTT females are confined to wheelchairs but on the other hand some RTT girls demonstrate a stable condition or even positive dynamics (up to 60% in some observations).
In 1988 the Rett Syndrome Diagnostic Criteria Work Group established 9 obligate, 8 supplementary and 7 excluding diagnostic criteria (21) . The cases fulfilling all obligate criteria are defined as the classical form of RTT. It should be emphasized that female sex is not an obligate criterion, thus the possibility of classic RTT incidence in males exists (14, 22) . Beside classic RTT, five distinct forms of atypical cases have been delineated on the basis of these diagnostic criteria (23) . These variants are characterized by incomplete fulfillment of all obligate criteria and can be either mild or severe. Milder variants include the so called "forme fruste", the late regression onset variant and the preserved speech variant (23, 24) . The more severe variants include the congenital form and the early seizure onset variant (23, 25) . In Sweden the incidence of Rett syndrome S G Vorsanova et al atypical RTT variants is about 20% (2) . However the contribution of atypical variants in RTT prevalence is estimated as 11% and lower. Among atypical forms of RTT the preserved speech variant is considered as the most frequent (26) .
Cytogenetic and molecular cytogenetic studies of RTT
Mutations in the MECP2 gene are considered as the primary cause of RTT, however mutations are found in 35-90% cases. Most comprehensive studies in classic RTT have shown MECP2 mutation incidence of more than 80% (27) . However, the involvement of other gene mutations or genetic abnormalities associated with RTT should be taken into account. Therefore, a study of chromosomal abnormalities in RTT should be useful for determining other genetic cause of RTT in females without MECP2 mutation or indicate the loci that expression is repressed by MeCP2 protein. There are a number of reports about chromosomal abnormalities in RTT affected females and mothers of RTT children (Table 2) . Taking into account the prevalence of RTT one can conclude that chromosomal aberrations are not common in RTT and this fact could be used in the differential diagnosis of the disease. It should be also emphasized that the majority of chromosomal abnormalities mentioned above are unlikely to be related etiologically to RTT. However, a study of chromosomal abnormalities in RTT affected females is useful to survey other genetic abnormalities involved in the RTT pathogenesis, especially in those females without MECP2 mutations. Unfortunately the majority of chromosomal abnormalities in RTT were described before 1999, thus very few reports are suitable for investigation of additional genetic causes in RTT. Most of chromosomal abnormalities found in RTT patients may be associated with other conditions, and therefore their occurrence in RTT patients can be explained by a simple coincidence. However, some of them could reveal a candidate gene region for RTT cases without MECP2 mutations. Analyzing the data on chromosomal abnormalities in RTT we have suggested that these candidate regions are 2q34, 3p25.1-3p25.2, 11q23.3, 13q22.1-13q21.2, Xp11.22 and Xp22.11, Xq28 or Xp23.
In addition there are several reports about enlargement of heterochromatin region in chromosome 9 and pericentric inversions in chromosomes 2 and 9 in RTT girls (34, 43, 44) . Subsequently these findings have lead to the suggestion that these rearrangements in heterochromatin regions could be caused by the abnormal function of the mutated MeCP2 protein, as this protein is involved in chromatin remodeling (45) . It has been also noticed that fragility of chromosome X fra(X)(p22) is present in RTT affected children (46) . In the light of MECP2 mutation association with RTT it may also be of significance for genetic studies of molecular processes leading to RTT. However, subsequent investigation of this phenomenon have shown insignificant association between fra(X)(p22) and RTT (44, 47) .
Preliminary studies have shown a statistically significant low-grade chromosome X mosaisism in neurons of the brain in patients with some psychiatric diseases (schizophrenia) (48) . There was proposed a hypothesis that in a number of neuropsychiatric diseases (including autistic spectrum disorders) mosaic forms of aneuploidy in the brain tissue could be present. Although it seems to be speculative regarding RTT, the occurrence of low-grade chromosome mosaicism in the brain tissue could affect the phenotypic manifestations of autistic spectrum disorders including RTT or RTTlike diseases.
Mapping of the RTT gene
Approximately 99% of RTT cases are sporadic. Therefore the RTT gene mapping has been of great difficulty. However, some familial cases of RTT with maternal inheritance of the disease have been described (27) . As the disease affects primarily girls and the cases of RTT in males were associated with a 47,XXY karyotype (22) or male fetal lethality, an X-linked dominant inheritance mode of RTT was proposed (49) . There were a number of reports about monozygotic and dizygotic twins with RTT. All monozygotic twins were concordant for RTT and dizygotic twins were discordant (50) .
The genealogical RTT research project in Sweden has shown that about half of RTT females from 128 families have a common founder. The conclusion of this study was that there is a common genetic background of these cases (51) . Subsequent studies of MECP2 mutations have shown that RTT in these families are not associated with the same mutation (52) . Thus the common genetic origin in Swedish RTT clusters is doubtful.
The translocations found to be associated with RTT (29, 30) were not useful for RTT gene mapping because of different chromosome X region involvement. The studies of rare RTT familial cases by conventional genome-wide linkage analysis revealed the linkage to markers in Xq28 (53) . Systematic screening for mutations in X-linked genes involved in central nervous system functions and located on Xq28 was performed. As a result RTT was found to be associated with mutations in the gene encoding methyl-CpG-binding protein 2 (MECP2) (4).
MeCP2 protein function
MECP2 gene is located on Xq28, transcribes from telomere to centromere and consists of 4 exons with coding region in exons 2-4. This gene is subjected to chromosome X inactivation (54) . MeCP2 protein is an abundant mammalian protein being a global transcriptional repressor. The particularity of the protein is the ability to bind with isolated methylated CpG. It consists of 486 amino-acids and contains two essential functional domains: 1. methyl-CpG-binding domain (MBD); 2. transcriptional repression domain (TRD) (55) .
In rodents MeCP2 protein is segregating throughout the metaphase chromosome arms and is concentrated in the pericentromeric heterochromatin, which contains highly methylated satellite DNA (56). A similar segregation was then observed in humans as well (57) . MeCP2 protein binds to methylated CpG without major impediment from the nucleosome surface (58) . It has been established that MeCP2 binds to methylated but not to unmethylated DNA (59) . Transcriptional silencing of genes is achieved by methylation of CpG in the promoter region. By investigating the possible involvement in transcriptionl repression, MeCP2 has been found to repress transcription from up to 2 kbps from the transcription initiation site (55) . The transcriptional repression is achieved through MeCP2 binding to isolated methylated CpG and initiating a complex containing histone deacetylase and corepressor Sin3A. This process leads to chromatin compartmentalization then the steric interaction of DNA and RNA-polymerase complex, effectively shutting off expression (60) . The MeCP2 protein has also been shown to interact with different DNA sequences in mice and Xenopus (56), however these findings are not well explained in the light of molecular processes leading to clinical manifestation in RTT females and will not be mentioned further in the present review.
The studies of MECP2 knockout mice have shown that the protein is essential for male mouse embryo development (61) . Beginning in 1999, there have been several MeCP2 protein expression studies. It has been shown that MECP2 is highly expressed in neurons in neonatal period (62) ; in mice MECP2 expression in olfactory receptor neurons occurs in mature neurons only before synaptogenesis (63) . It has been demonstrated that MeCP2 protein binds to the major-satellite DNA in large neurons (64) . All these findings concerning MeCP2 protein expression are in accordance with the pathogenic effect of MECP2 mutations leading to RTT in humans. However, the major part of such studies is based on the assumption that expression of MECP2 is similar in mice and humans (56) but it should be mentioned that the processes in human cells with mutated MECP2 gene could be more complex than in mice.
MECP2 gene mutations in RTT girls
During last four years the studies of MECP2 mutations in RTT females have become an important part of the field of molecular and medical genetics of RTT. There were identified 218 different missense (substitution of one amino-acid by another in protein sequence) and nonsense (substitution of one triplet by stop-codon in DNA sequence) mutations in approximately 2,100 patients. There were also found about 300 deletions in MECP2 gene (loss of DNA sequence). The overall mutation detection rate is 61.7% (65) . The existence of free online database of MECP2 mutations RettBase IRSA MECP2 Variation Database (Australia) http://www.MECP2.chw.edu.au is simplifying the analysis of MECP2 mutation spectrum and allows rapid identification of the pathogenic nature of newly detected mutation.
The occurrence of MECP2 mutations is 70-90% in sporadic cases and about 50% in familial cases (27) . The spectrum of MECP2 mutations is very variable and probably depends on the particularity of the group studied ( Table 3 ). The mutation detection rate varies from 35 to 100%. Lower mutation rates were principally observed in the groups with an increased amount of familial cases known to be associated with lower mutation detection rate. Atypical cases are also associated with lower mutation rates, thus one can assume that there are a phenocopies of RTT probably associated with another genetic abnormalities.
The coding region is the most thoroughly screened for MECP2 mutations. However, the possibility of mutation localization in other regions of the gene is assumed (66) . It has been commonly pointed out that several polymorphisms and benign genetic variants of the coding region and noncoding region of MECP2 gene exist (65, 66) . Due to insufficient data obtained on MECP2 sequence variation in unaffected population the additional MECP2 sequence studies of healthy relatives is needed when new nucleotide change in MECP2 gene is detected. In cases when such studies are impossible it is recommended to describe the new variant as "unclassified" (65) .
Almost 70% of the reported mutations result from cytosine to thymine substitution occurring due to spontaneous deamination of methylated cytosine in CpG sites. This process probably explains the existence of eight recurrent mutations. They make up more than half of all mutations detected being principally located in MBD, TRD and intermediate region ( Figure 1 ). The high incidence of recurrent mutations is simplifying molecular genetic diagnosis of RTT allowing the two-step PCRrestriction fragment length polymorphism testing. This technique compared to direct sequencing is more rapid and requires less financial expenses and appears to be quite useful taking into account the frequency of recurrent mutations (68) . In majority of cases the paternal origin of MECP2 mutations was observed (76, 77) . It seems to be in accordance with sporadic inheritance pattern of RTT and a hypothesis suggesting the high mortality rate among hemizygous males (49) . This data underlines the paternal germ line mutations as an essential mechanism for MECP2 mutations. However, the parental origin of MECP2 mutations was studied only in two reports and the high incidence of familial cases are described in other studies (73, 75) . Therefore, the true ratio of maternal/paternal derived chromosomes X with MECP2 mutation in RTT girls is not known.
Functional consequences of MECP2 mutations
The best studied functional consequences are those of recurrent mutations. We have already mentioned the male fetal lethality in MECP2 knockout mice (61) . There was another study of MECP2 mutation functional consequences in humans. It has been revealed that missense mutations being principally located in MBD affect the function of methyl binding. T158M and R133C missense mutations have been suggested to be associated with the most severe RTT phenotype caused by mutations located in MBD (78) . However, in some studies R133C missense mutation has been described as producing a relatively milder phenotype (72) . Analysis of nonsense mutations functional consequences has shown that mutations R168X and R255X affect the methyl binding and transcriptional repression function and therefore could be considered as the most pathogenic. Other nonsense mutations in TRD affect the function of this domain. The recurrent missense mutation R306C located in TRD has not been associated with abnormal MeCP2 protein function (78) . To our knowledge there are no any other reports on MECP2 mutation functional consequences. It is noteworthy that these findings raise a question about pathogenic value of R306C recurrent mutation. In addition the data on MeCP2 protein involvement in transcriptional repression indicates that the loss of methyl binding function leads to the loss of transcription repression function. Therefore the comparative pathogenic value analysis of MECP2 mutations leading to loss of the different proteins functions is not fully understood.
MECP2 mutations exceed beyond RTT
Some familial cases of RTT are characterized by the presence of MECP2 mutations coupled with completely skewed inactivation of chromosome X in unaffected mothers. It indicates that in some cases pathogenic mutation could be found in females without any neurological abnormality (asymptomatic mutation carrier).
The studies of MECP2 mutations in males 
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have demonstrated their association with a broad spectrum of neurological and psychiatric diseases (79) ( Table 4 ). Classic RTT in males has been observed only with a mosaic or non-mosaic 47,XXY karyotype (22, 43, 71) and somatic mosaicism of MECP2 mutation (81) . It is noteworthy that MECP2 mutations were found to be the cause of 2% cases of nonspecific X-linked mental retardation (one of the most common cause of mental retardation in males) (85) . Basing on these results another group revealed A140V mutation to be the cause of 1% cases of X-linked mental retardation (86) . Therefore the impact of MECP2 mutations on congenital neurological abnormality in males is of great significance.
The study of a boy with classic RTT and R270X mutation has indicated tissue specific 47,XXY/46,XY mosaicism (43) . However, other investigations of boys with RTT clinical features have not taken it into account. Therefore, for further studies of RTT boys the cytogenetic or molecular cytogenetic analysis in different tissues is recommended.
Such heterogeneity of clinical manifestation in males with MECP2 mutations is not yet well explained. However the pathogenic value of some MECP2 mutation in males is not determined, thus it is reasonable to suspect that some diseases mentioned above are not associated with MECP2 mutations.
Epigenetic phenomena and RTT
Epigenetic phenomena are defined as heritable changes in gene expression occurring without qualitative or quantitative DNA sequence changes. RTT being an X-linked disease is primarily associated with the epigenetic process of X chromosome inactivation (XCI) and related phenomena such as delayed replication of chromosome X. XCI is a transcriptional silencing of X-linked genes of one parental derived chromosome X in a female cell. Usually, the equal contribution of paternal and maternal chromosome X activity (50:50) in a whole female organism is observed. However, stochastically or due to some abnormalities a deviation of this contribution can occur. This phenomenon is known as skewed XCI or non-random XCI.
Recent studies have demonstrated skewed XCI to be a common feature of X-linked mental retardation. However, there are no precise data on XCI patterns in RTT affected females. The initial studies of XCI patterns in RTT girls were carried out in order to determine the genetic cause of the disease and have revealed an increased occurrence of skewed XCI (89, 90) . Another study also aimed to associate RTT with a chromosome X abnormality failed to reveal any significant increase of skewed XCI occurrence (50) . Thus, there is no true association of RTT with skewed or random XCI. Since 1999, there have been no further targeted studies of skewed XCI in a RTT affected group. In a study of MECP2 mutations and XCI effect on RTT phenotype it has been revealed that 43% of girls had a skewed XCI (74) . Although there was no control for the XCI study, the occurrence of skewed XCI is significantly higher than it has been found in other studies for unaffected population. Summarizing the data on XCI in RTT girls obtained before 2002 it has been found that only 19% (38 from 201 patients) had a skewed XCI pattern. In this study XCI patterns were investigated in the post-mortem RTT brain samples and all eight specimens were characterized by random XCI (91). It is noteworthy that there are a number of reports about asymptomatic female carriers of pathogenic MECP2 mutations and skewed XCI having an RTT affected child with random XCI (83, 88) . These data have suggested the occasional occurrence of skewed XCI in RTT females and their unaffected mothers (91) . It has been shown that extremely skewed XCI is common in familial RTT cases without MECP2 mutations being present in girls and their unaffected mothers as well. A model for familial RTT inheritance suggests an X linked locus abnormally escaping XCI and the presence of a skewed XCI in carrier women (92) . This fact indicates that analysis of XCI is an important approach for diagnosis and survey of genetic cause in RTT females without MECP2 mutation.
The generally accepted mechanism of XCI skewing is that female cells with active mutated chromosome X are associated with selective disadvantage in comparison with female cells with inactive mutated chromosome X. In light of the data obtained on XCI in RTT females this mechanism seems to be unlikely. There could be other mechanisms leading to skewed XCI in some RTT females possibly associated with abnormal MeCP2 protein functions through abnormal transcriptional repression of X-linked genes.
The studies of replication patterns in RTT females by cytogenetic techniques have indicated unusual staining (type C) to be present in about 90% of children not observed in females without RTT clinical features. The type C replication pattern represents a disturbance in the sequence of replication in an inactive chromosome X (22, 43, 44, 47) . This data could provide further evidence about mutated MeCP2 protein action in a cell of RTT affected females. The epigenetic phenomenon of the disturbance in the sequence of replication is found in RTT girls without MECP2 mutation as well and therefore is applicable for confirmation and preclinical diagnosis of RTT (43) . The occurrence of this replication disturbance have lead us to propose a hypothesis suggesting that some loci (or genes), which are normally inactive in the late-replicating X-chromosome, are activated in RTT patients. According to our data, loss of temporal control of replication (abnormal replication pattern) at regions of Xq23 and Xq28 could exist in RTT girls. Molecular cytogenetic studies also indicated that some loci from the region Xq28 escape inactivation in late chromosome X replication. Therefore, region Xq28 could contain genes escaping X-inactivation and expressing from the human active and inactive chromosomes X in RTT. These results support the hypothesis proposing the disturbances in dosage compensation effect due to aberrant activation of genes in inactive chromosome X (bi-allelic expression instead of mono-allelic) (93) . This is in accordance with data obtained from mapping of loci involved in familial cases of RTT without MECP2 mutations (92) . Our results indicate that the MECP2 gene itself could escape X-inactivation and reduce the pathogenic effect of mutated allele in RTT and this can be taken into account for explanation of the RTT neurological abnormality lack in neonatal period (93) .
In conclusion, about the role of epigenetic phenomena in RTT it should be emphasized that although skewed XCI is not revealed to be a feature of RTT, this process is of great significance in RTT case descriptions. The replication disturbances in RTT girls are giving the explanation of genetic and epigenetic features that contributes to the complex nature of this severe neurological disease
Genotype-phenotype correlations
Although genetic and epigenetic peculiarities of RTT are quite well studied, the majority of genotype-phenotype correlation studies have yielded conflicting results. It is principally due to the complexity of the combined effect of MECP2 mutation type and location as well as XCI. There were a number of studies underlining the correlation between RTT severity and MECP2 mutation type and location (70, 72) . However, subsequent studies and reviews failed to find any correlation between these RTT features and therefore, concluded that skewed XCI largely determines the RTT phenotype (66, 74, 91) . It is noteworthy that the direction of XCI skewing could be against chromosome X with mutation as well as without mutation (53, 91, 94) . Thus, the difference of XCI skewing direction should be taken into account for the genotype-phenotype studies. The XCI effect on RTT phenotype could be as positive (leading to the milder disease manifestation) as negative (leading to the more severe disease manifestation) therefore these two effects would compensate each other in the whole group of girls studied.
Another problem of such studies is that the functional consequence of mutation being of the same type is not always identical. The study of genotype-phenotype correlations in males is also of interest as the XCI effect in males is absent (because of bearing only one chromosome X). However, such investigations failed to reveal any significant association between mutation type and clinical manifestations in males (65, 66) . This is due in major part to the heterogeneity of neurological abnormalities caused by MECP2 mutations in male infants. In addition our studies of boys with classical RTT have shown that 47,XXY/46,XY mosaicism could be tissue specific and therefore this could also make a contribution to the phenotype of RTT in males (43) .
The difficulty of genotype-phenotype correlation studies also arise from the imperfection of the phenotype scoring systems because different RTT clinical features have a diverse effect on the whole severity of disease and therefore the evaluation of different symptoms. In developing a scoring system, it is also important to provide a balanced score for each clinical feature assessed in order not to skew the results.
In conclusion, we can recommend for further investigations targeted revealing genotypephenotype correlations to consider the XCI skewing direction (against chromosome X with/without mutation) and cases with known functional consequence of classified MECP2 mutations. For better results it is also needed to use a higher scoring point amount for the most typical symptoms of RTT.
Conclusion and perspectives
Although RTT has been studied for quite a long time, there are a number of poorly understood genetic and epigenetic features principally related to the molecular processes and alterations leading to disease manifestation. The clinical features and MECP2 mutation spectrum are well described. The growing number of MeCP2 protein expression studies brings a new insight into understanding of molecular processes leading to the complex neurological abnormalities in RTT girls. The epigenetic phenomena such as replication sequence disturbance and late replication of some X-linked loci are a common feature of RTT and probably explain some neurological abnormalities occurring in RTT affected children. Recent studies have revealed that MECP2 protein functions to repress the expression of the BDNF gene (95) . The epigenetic disturbance in RTT affected females (with or without MECP2 mutations) mentioned above as well as the data on MECP2 segregation in a human cell are suggesting that additional genes could be subjected to MeCP2 protein regulation. The search of additional genetic abnormalities in RTT has been further complicated by the determination of a MeCP2 protein isoform which could play a role in RTT pathogenesis being more abundant in brain tissue than the first form identified (96) . The problem of the correlation between complex neurological features of RTT and MECP2 mutation type and location as well as XCI is not yet solved. The latest studies of genotypephenotype correlation have indicated the limitations of analyses of correlation between phenotype and mutation type and location in larger mutation groups (74, 97) . One of last genotype-phenotype correlation studies has proposed a revised ordinal scoring system that allows correction for patient ages, but do not comprise the possible unbalanced XCI effect (97) . Therefore, in order to carry out such studies in future the modified phenotype scoring systems comprising XCI effect should be developed and the analysis of the cases with mutations having the same functional consequence as well as consideration of the XCI skewing direction (against chromosome X with/without mutation) is recommended.
